| scholarly article | Q13442814 |
| P50 | author | Jose Vina | Q72143204 |
| Gabriella Testa | Q83310717 | ||
| Alessandro Mauro | Q41333345 | ||
| Paola Gamba | Q58954690 | ||
| Gabriella Leonarduzzi | Q58954705 | ||
| P2093 | author name string | Fiorella Biasi | |
| Giuseppe Poli | |||
| Simona Gargiulo | |||
| Michela Guglielmotto | |||
| Elena Tamagno | |||
| Barbara Sottero | |||
| P2860 | cites work | Role of Protein Aggregation in Mitochondrial Dysfunction and Neurodegeneration in Alzheimer's and Parkinson's Diseases | Q22241397 |
| Alzheimer's Disease | Q22248111 | ||
| A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families | Q27860677 | ||
| Alzheimer's disease: the cholesterol connection | Q28186482 | ||
| On the turnover of brain cholesterol in patients with Alzheimer's disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells | Q28204125 | ||
| Differential expression of cholesterol hydroxylases in Alzheimer's disease | Q28262249 | ||
| Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation | Q28613091 | ||
| A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells | Q29547557 | ||
| Adverse stress, hippocampal networks, and Alzheimer's disease | Q33708011 | ||
| Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment | Q33740552 | ||
| Brain cholesterol: long secret life behind a barrier. | Q33975527 | ||
| Statins and the risk of dementia | Q34511970 | ||
| Substrate deprivation therapy: a new hope for patients suffering from neuronopathic forms of inherited lysosomal storage diseases | Q34584825 | ||
| Oxidized products of cholesterol: dietary and metabolic origin, and proatherosclerotic effects (review). | Q35054306 | ||
| Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease | Q35782497 | ||
| Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease | Q35978920 | ||
| Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease | Q36604677 | ||
| Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. | Q36658177 | ||
| Alzheimer disease, the two-hit hypothesis: an update | Q36671778 | ||
| Causes of oxidative stress in Alzheimer disease. | Q36866947 | ||
| Cholesterol oxidation products and disease: an emerging topic of interest in medicinal chemistry. | Q37387429 | ||
| Cytotoxic effects of oxysterols associated with human diseases: Induction of cell death (apoptosis and/or oncosis), oxidative and inflammatory activities, and phospholipidosis. | Q37402916 | ||
| Cholesterol oxidation products in the vascular remodeling due to atherosclerosis. | Q37402920 | ||
| Amyloid oligomers: formation and toxicity of Abeta oligomers | Q37690827 | ||
| Docosahexaenoic acid and synaptic protection in Alzheimer's disease mice | Q37704813 | ||
| Oxidative stress in Alzheimer disease: a possibility for prevention | Q37731603 | ||
| A kinetic model for beta-amyloid adsorption at the air/solution interface and its implication to the beta-amyloid aggregation process | Q39324732 | ||
| Cholesterol potentiates beta-amyloid-induced toxicity in human neuroblastoma cells: involvement of oxidative stress | Q40010770 | ||
| Oxidation of cholesterol by amyloid precursor protein and beta-amyloid peptide. | Q40481988 | ||
| Normal and abnormal biology of the beta-amyloid precursor protein | Q40766055 | ||
| Neurotoxicity of 24-hydroxycholesterol, an important cholesterol elimination product of the brain, may be prevented by vitamin E and estradiol-17beta | Q40789767 | ||
| A COLORIMETRIC MICRO-METHOD FOR THE DETERMINATION OF GLUTATHIONE | Q42965670 | ||
| Oxidative damage is the earliest event in Alzheimer disease | Q43696731 | ||
| Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia: evidence that simvastatin affects cholesterol metabolism in the human brain | Q43885523 | ||
| Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer's disease compared to healthy controls | Q43975879 | ||
| Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2). | Q44111677 | ||
| Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease | Q44411234 | ||
| Cholesterol and APOE genotype interact to influence Alzheimer disease progression | Q44907918 | ||
| Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain. | Q45292335 | ||
| Identification of an NADH plus iron dependent, Ca2+ activated hydrogen peroxide production in synaptosomes | Q46664405 | ||
| Oxidation as a crucial reaction for cholesterol to induce tissue degeneration: CD36 overexpression in human promonocytic cells treated with a biologically relevant oxysterol mixture. | Q46709404 | ||
| Mannosylated liposomal flavonoid in combating age-related ischemia-reperfusion induced oxidative damage in rat brain | Q46946433 | ||
| The neurotoxic effect of 24-hydroxycholesterol on SH-SY5Y human neuroblastoma cells. | Q48301677 | ||
| Early glycoxidation damage in brains from Down's syndrome. | Q48512671 | ||
| NT2 neurons, a classical model for Alzheimer's disease, are highly susceptible to oxidative stress. | Q53236299 | ||
| Total cholesterol levels and the risk of mild cognitive impairment and Alzheimer's disease. | Q53284275 | ||
| P433 | issue | 3 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 403-417 | |
| P577 | publication date | 2011-04-05 | |
| P1433 | published in | Aging Cell | Q2221073 |
| P1476 | title | Interaction between 24-hydroxycholesterol, oxidative stress, and amyloid-β in amplifying neuronal damage in Alzheimer's disease: three partners in crime | |
| P478 | volume | 10 |
| Q38335068 | 24(S)-Hydroxycholesterol as a Modulator of Neuronal Signaling and Survival |
| Q39536523 | 24(S)-hydroxycholesterol induces neuronal cell death through necroptosis, a form of programmed necrosis |
| Q92862273 | A Crosstalk Between Brain Cholesterol Oxidation and Glucose Metabolism in Alzheimer's Disease |
| Q55364537 | A silver lining for 24-hydroxycholesterol in Alzheimer's disease: The involvement of the neuroprotective enzyme sirtuin 1. |
| Q37946306 | Amyloid-β production: major link between oxidative stress and BACE1. |
| Q42314615 | Amyloidogenicity and toxicity of the reverse and scrambled variants of amyloid-β 1-42 |
| Q38260820 | Apoptosis in Alzheimer's disease: an understanding of the physiology, pathology and therapeutic avenues |
| Q39326560 | Aβ1-42-mediated down-regulation of Uch-L1 is dependent on NF-κB activation and impaired BACE1 lysosomal degradation |
| Q34200691 | Beta-amyloid peptides enhance the proliferative response of activated CD4CD28 lymphocytes from Alzheimer disease patients and from healthy elderly. |
| Q48221935 | Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer's disease. |
| Q38937092 | Current Knowledge about Oxysterols: A Review. |
| Q37939806 | Dietary lipids and their oxidized products in Alzheimer's disease. |
| Q50540565 | Does serum uric acid act as a modulator of cerebrospinal fluid Alzheimer's disease biomarker related cognitive decline? |
| Q21129438 | Exercise-induced cognitive plasticity, implications for mild cognitive impairment and Alzheimer's disease |
| Q39273375 | Fatty acid transporting proteins: Roles in brain development, aging, and stroke |
| Q28538558 | Loading into nanoparticles improves quercetin's efficacy in preventing neuroinflammation induced by oxysterols |
| Q38111373 | NADPH oxidase and neurodegeneration |
| Q64267176 | NF-κB-mediated inflammatory damage is differentially affected in SH-SY5Y and C6 cells treated with 27-hydroxycholesterol |
| Q35669877 | Neuronal DNA damage response-associated dysregulation of signalling pathways and cholesterol metabolism at the earliest stages of Alzheimer-type pathology |
| Q38973023 | Oxidized LDL lipids increase β-amyloid production by SH-SY5Y cells through glutathione depletion and lipid raft formation |
| Q27023315 | Oxidized cholesterol as the driving force behind the development of Alzheimer's disease |
| Q26864594 | Oxysterols in the pathogenesis of major chronic diseases |
| Q38803761 | Protein engineering of microbial cholesterol oxidases: a molecular approach toward development of new enzymes with new properties. |
| Q34418826 | Steady-state levels of retinal 24S-hydroxycholesterol are maintained by glial cells intervention after elevation of intraocular pressure in the rat. |
| Q55365663 | Strikingly different effects of cholesterol and 7-ketocholesterol on lipid bilayer-mediated aggregation of amyloid beta (1-42). |
| Q39016322 | The enzyme lecithin-cholesterol acyltransferase esterifies cerebrosterol and limits the toxic effect of this oxysterol on SH-SY5Y cells |
| Q48393490 | The level of 24-Hydroxycholesteryl Esters is an Early Marker of Alzheimer's Disease. |
| Q38023563 | The link between altered cholesterol metabolism and Alzheimer's disease. |
| Q92970041 | The role of NOX inhibitors in neurodegenerative diseases |
| Q83133604 | Trans fatty acids enhanced β-amyloid induced oxidative stress in nerve growth factor differentiated PC12 cells |
| Q39017085 | Up-regulation of β-amyloidogenesis in neuron-like human cells by both 24- and 27-hydroxycholesterol: protective effect of N-acetyl-cysteine |
| Q48389172 | Vitamin E supplementation modulates the biological effects of omega-3 fatty acids in naturally aged rats |
| Q33355586 | Vitiligo: a possible model of degenerative diseases |
Search more.